Our Portfolio

Building Advanced Pharmaceutical
Drug Products for Global Markets.

We are committed to advancing healthcare by developing high-quality, regulatory-compliant pharmaceutical drug products for global markets. Our product portfolio spans a wide range of therapeutic categories, including cardiovascular, oncology, diabetes, antivirals, antibiotics, and more. With a strong track record in development, filings, approvals, and continuous product development, Aizant continues to expand its presence across multiple geographies, including the United States, Canada, Europe, and Rest of the World (ROW) markets.

Regional Portfolio Overview

We have a proven history of filing, receiving approvals, and advancing products through development, with a solid pipeline that demonstrates our growing footprint in the global pharmaceutical market.

United States

Filed: 44 products
Approved: 27 products
Tentative Approvals: 5 products
Pipeline Products: 18+ products

Europe

Filed: 54 products
Approved: 36 products
Pipeline Products: 15+ products

Rest of World

Filed: 124 products
Approved: 78 products
Pipeline Products: 75+ products

Canada

Filed: 8 products
Approved: 4 products
Tentative Approvals: 2 products
Pipeline Products: 5+ products

This strong portfolio demonstrates our ability to find opportunities, navigate regulatory requirements, and deliver innovative products to patients across the globe. Our deep understanding of market needs and evolving trends enables us to stay ahead of the competition while expanding our product offerings.

Innovative Technologies in Development

Aizant uses cutting-edge technologies and superior formulation processes to develop a wide range of products.

505(b)(2) Applications

We specialize in 505(b)(2) filings to bring new formulations and combination products to market by leveraging existing data for faster regulatory approval processes.

Smart Development

We use sophisticated technologies and streamlined processes to generate cost-effective and scalable formulations for global markets.

P-IVs

We specialize in the developing P-IVs and ensure compliance with regulatory standards at all stages.

Our Business Models

Co-Development

We work with industry partners on co-development projects to jointly bring new products to market. This business model allows for shared expertise, resources, and risk mitigation, ensuring successful product launches and continued growth in global markets.

Out-Licensing

We provide out-licensing opportunities for our developed products, allowing partners to take advantage of our innovative formulations and technologies in different markets. Our portfolio of approved and pipeline products provides diverse out-licensing options for companies seeking to expand their therapeutic offerings.

Explore our product portfolio. Get in touch with our experts.